KAIST 생명과학과동창회
  • News & Events
  • News

News

Antibiotic tolerance study paves way for new treatments


A new study identifies a mechanism that makes bacteria tolerant to penicillin and related antibiotics, findings that could lead to new therapies that boost the effectiveness of these treatments.


Antibiotic tolerance is the ability of bacteria to survive exposure to antibiotics, in contrast to antibiotic resistance, when bacteria actually grow in the presence of antibiotics. Tolerant bacteria can lead to infections that persist after treatment and may develop into resistance over time.

The study in mice, “A Multifaceted Cellular Damage Repair and Prevention Pathway Promotes High Level Tolerance to Beta-lactam Antibiotics,” published Feb. 3 in the journal EMBO Reports, reveals how tolerance occurs, thanks to a system that mitigates iron toxicity in bacteria that have been exposed to penicillin.


“We’re hoping we can design a drug or develop antibiotic adjuvants that would then basically kill off these tolerant cells,” said senior author Tobias Dörr, assistant professor of microbiology in the Weill Institute for Cell and Molecular Biology in the College of Agriculture and Life Sciences.


Co-authors included Ilana Brito, the Mong Family Sesquicentennial Faculty Scholar and assistant professor in the Meinig School of Biomedical Engineering in the College of Engineering, and Lars Westblade, associate professor of pathology and laboratory medicine at Weill Cornell Medicine.


Some bacteria, including the model bacterium used in the study, Vibrio cholerae, which causes cholera in humans, are remarkably tolerant to penicillin and related antibiotics, known as beta lactam antibiotics. It has been known for a long time that beta-lactam antibiotics break down bacterial cell walls, but how bacteria survive loss of their cell walls was poorly understood.


In the study, the researchers developed a V. cholerae mutant that lacked a two-component damage repair response system that controls a gene network encoding diverse functions. Without the system, known as VxrAB, when the cell wall is damaged by antibiotics, the transfer of electrons across the cell membrane goes awry, leading to electrons ending up on the wrong molecules. This misdirection causes hydrogen peroxide to accumulate in the cell, which changes the oxidation state of cellular iron and disrupts signals for the cell to tell how much iron it has.   


In the presence of hydrogen peroxide, the mutant bacteria cannot sense how much iron has been acquired, and it behaves as if it is iron-starved and seeks to acquire more iron. Left unchecked, these circumstances cause iron toxicity, which will kill the cell, according to the experiments the researchers conducted. In further tests with mutant V. cholerae bacteria, both in test tubes and in mice, the researchers showed that reducing the influx of iron increased the bacteria’s tolerance to beta lactams.


Fortunately for normal V. cholerae, exposure to antibiotics and the breakdown of the cell’s walls activate the VxrAB system, which works to repair cell walls and downregulates iron uptake systems, and thereby creates antibiotic tolerance. More study is needed to understand what triggers the VxrAB system in the presence of beta-lactam antibiotics.


The research opens the door for developing new drugs that could be combined with antibiotics to exploit oxidative damage and iron influx in tolerant bacteria. In future work, the researchers will search for parallel mechanisms of tolerance in other bacterial pathogens.


Jung-Ho Shin, a postdoctoral researcher in Dörr’s lab, is the paper’s first author. Co-authors include researchers from the Korea Advanced Institute of Science and Technology, the Korea Advanced Institute of Science and Technology, and the Intelligent Synthetic Biology Center in Korea.

The study was funded by the National Research Foundation of Korea and the National Institutes of Health.


https://news.cornell.edu/stories/2021/02/antibiotic-tolerance-study-paves-way-new-treatments

https://www.miragenews.com/antibiotic-tolerance-study-paves-way-for-new-516267/



List of Articles
번호 제목 글쓴이 날짜 조회 수
141 송지준 교수, Genes & Dev. 게재 (2013.3) 과사무실 2013.03.21 13366
140 송지준 교수, J.Am.Chem.Soc. 게재 (2013.10) 과사무실 2013.10.18 14456
139 송지준 교수, PNAS 게재 (2012.8) 과사무실 2012.12.10 14930
138 송지준 교수, 김은지 박사 Molecular Cell에 논문 게재(2015) / Prof. Ji-Joon Song and PhD. Eun-Ji Kim published a paper at Molecular Cell (2015) 과사무실 2015.07.29 14857
137 송지준교수, 조수민 연구교수, 장주원 박사과정학생 nature communications 논문 게재 file 생명과학과 2020.01.02 57634
136 양한슬 교수님_ 서경배과학재단 2021년 신진과학자 선정 file 생명과학과 2021.08.31 1034
135 오병하 교수, 제 9회 아산의학상 수상 file 생명과학과 2016.03.14 18603
134 오병하 교수님_자연에 없는 고감도 단백질 센서 제작 플랫폼 개발 생명과학과 2021.02.08 1212
133 우주연 학생(김은준 교수님 Lab), 로레알-유네스코 펠로쉽 수상 과사무실 2009.06.23 17894
132 윤기준 교수, '2019 서경배과학재단 신진 과학자' 선정 file 생명과학과 2019.09.23 6346
131 이규리 학생(박태관 교수님 Lab), ICMAT 2009 & IUMRS-ICA 2009 Best Poster Award 수상 과사무실 2009.07.13 13873
130 이균민 교수 생명과학과 학과장 취임 과사무실 2007.09.13 13031
129 이균민 교수, 교무처장 인사 발령 과사무실 2010.07.15 12186
128 이상기 박사 한국생명공학연구원장 취임 과사무실 2005.07.12 14028
127 이상열 교수(박사 85) KAIST 올해의 동문 선정 과사무실 2005.01.04 15635
126 이승재 교수, 올리브유의 노화 방지 및 장수 효과 입증 file 생명과학과 2019.08.22 6028
125 이승재 교수, 한성과학상 수상 file 생명과학과 2019.07.01 6765
124 이승재 교수님_One More Key to Human Longevity Found After Worm Research 생명과학과 2020.07.03 11295
123 이승희 교수, 송유향, 김재현 박사과정 학생 Neuron 게재 file 생명과학과 2017.02.13 18299
122 이승희 교수님_KAIST, 뇌 인지기능 높이는 물질 발견… 치매 치료 효과 기대 file 생명과학과 2020.04.26 5398
Board Pagination Prev 1 ... 11 12 13 14 15 16 17 18 19 20 ... 23 Next
/ 23